Commission Implementing Regulation (EU) 2025/1905

Contents

3,360 provisions, too many to show on one page. Open a part or section to read it with its history and connections, or search inside the text.

1. THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) No 528/2012 of the European Parl
   1. (1) On 19 April 2016, Schülke & Mayr GmbH submitted an application to the European Chemicals Agency (‘the Agency’) in accordance with Article 43(1) of Regulatio
   2. (2) ‘desmanol pure’ contains propan-2-ol as the active substance, included in the Union list of approved active substances referred to in Article 9(2) of Regula
   3. (3) On 13 June 2024, the evaluating competent authority submitted, in accordance with Article 44(1) of Regulation (EU) No 528/2012, an assessment report and the
   4. (4) On 13 December 2024, the Agency submitted to the Commission its opinion, the draft summary of the biocidal product characteristics (‘SPC’) of ‘desmanol pure
   5. (5) The opinion concludes that ‘desmanol pure’ is a biocidal product family within the meaning of Article 3(1), point (s), of Regulation (EU) No 528/2012, that
   6. (6) On 8 January 2025, the Agency transmitted to the Commission the draft SPC in all the official languages of the Union in accordance with Article 44(4) of Reg
   7. (7) The Commission concurs with the opinion of the Agency and considers it therefore appropriate to grant a Union authorisation for the biocidal product family
   8. (8) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,
2. 1
3. 2
4. Summary of product characteristics for a biocidal product family
   1. Desmanol pure
   2. Product type(s)
   3. PT01: Human hygiene
   4. Authorisation number: EU-0033833-0000
   5. R4BP asset number: EU-0033833-0000
   6. Part I — first information level
   7. Part II — second information level meta spc(s)